{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T03:12:43Z","timestamp":1793502763578,"version":"4.5.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["2018\/29\/B\/NZ7\/02662"],"award-info":[{"award-number":["2018\/29\/B\/NZ7\/02662"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["2019\/35\/B\/NZ7\/03651"],"award-info":[{"award-number":["2019\/35\/B\/NZ7\/03651"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.phrs.2021.105739","type":"journal-article","created":{"date-parts":[[2021,6,23]],"date-time":"2021-06-23T09:22:35Z","timestamp":1624440155000},"page":"105739","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":61,"special_numbering":"C","title":["Hepatic stellate cells role in the course of metabolic disorders development \u2013 A molecular overview"],"prefix":"10.1016","volume":"170","author":[{"given":"Nabila","family":"Bourebaba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krzysztof","family":"Marycz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.phrs.2021.105739_bib1","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.3390\/ijms21062027","article-title":"Recent advances in practical methods for liver cell biology: a short overview","volume":"21","author":"Torres","year":"2020","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.phrs.2021.105739_bib2","series-title":"Pathobiology of Human Disease","first-page":"1809","article-title":"Hepatic fibrosis and cirrhosis","author":"Rockey","year":"2014"},{"key":"10.1016\/j.phrs.2021.105739_bib3","series-title":"Stem Cells and Cancer in Hepatology","first-page":"1","article-title":"Molecular mechanisms of liver development: lessons from animal models","author":"Miyamura","year":"2018"},{"key":"10.1016\/j.phrs.2021.105739_bib4","series-title":"Stellate Cells in Health and Disease","first-page":"163","article-title":"Stellate cells in alcoholic hepatitis","author":"Mandal","year":"2015"},{"issue":"1","key":"10.1016\/j.phrs.2021.105739_bib5","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1136\/gut.2004.042127","article-title":"Human hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis of hepatic fibrosis","volume":"54","author":"Xu","year":"2005","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.phrs.2021.105739_bib6","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1053\/j.gastro.2006.10.014","article-title":"Insulin resistance accelerates a dietary rat model of nonalcoholic steatohepatitis","volume":"132","author":"Ota","year":"2007","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.phrs.2021.105739_bib7","doi-asserted-by":"crossref","DOI":"10.21037\/atm.2020.02.184","article-title":"The cellular pathways of liver fibrosis in non-alcoholic steatohepatitis","volume":"8","author":"M\u00e9ndez-S\u00e1nchez","year":"2020","journal-title":"Ann. Transl. Med"},{"issue":"1","key":"10.1016\/j.phrs.2021.105739_bib8","first-page":"9","article-title":"Non alcoholic fatty liver disease and metabolic syndrome","volume":"13","author":"Paschos","year":"2009","journal-title":"Hippokratia"},{"issue":"6","key":"10.1016\/j.phrs.2021.105739_bib9","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s00535-008-2180-y","article-title":"Molecular mechanism of hepatic stellate cell activation and antifibrotic therapeutic strategies","volume":"43","author":"Li","year":"2008","journal-title":"J. Gastroenterol."},{"issue":"7\u20138","key":"10.1016\/j.phrs.2021.105739_bib10","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.addr.2009.03.011","article-title":"Transcriptional regulation of hepatic stellate cells","volume":"61","author":"Mann","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.phrs.2021.105739_bib11","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.metabol.2018.09.001","article-title":"cGMP-dependent protein kinase I (cGKI) modulates human hepatic stellate cell activation","volume":"88","author":"Franko","year":"2018","journal-title":"Metabolism"},{"issue":"1","key":"10.1016\/j.phrs.2021.105739_bib12","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jhep.2007.04.002","article-title":"Insulin resistance in hepatocytes and sinusoidal liver cells: mechanisms and consequences","volume":"47","author":"Leclercq","year":"2007","journal-title":"J. Hepatol."},{"issue":"7","key":"10.1016\/j.phrs.2021.105739_bib13","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1172\/JCI29069","article-title":"Inflammation and insulin resistance","volume":"116","author":"Shoelson","year":"2006","journal-title":"J. Clin. Investig."},{"issue":"2","key":"10.1016\/j.phrs.2021.105739_bib14","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1247\/csf.28.105","article-title":"Hepatic stellate cells: unique characteristics in cell biology and phenotype","volume":"28","author":"Sato","year":"2003","journal-title":"Cell Struct. Funct."},{"key":"10.1016\/j.phrs.2021.105739_bib15","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.5858\/2007-131-1728-HSCALF","article-title":"Hepatic stellate cells and liver fibrosis","volume":"131","author":"Moreira","year":"2007","journal-title":"Arch. Pathol. Lab. Med."},{"issue":"1","key":"10.1016\/j.phrs.2021.105739_bib16","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1152\/physrev.00013.2007","article-title":"Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver","volume":"88","author":"Friedman","year":"2008","journal-title":"Physiol. Rev."},{"issue":"9","key":"10.1016\/j.phrs.2021.105739_bib17","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s005350070045","article-title":"Hepatic stellate cells: a target for the treatment of liver fibrosis","volume":"35","author":"Wu","year":"2000","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.phrs.2021.105739_bib18","series-title":"Comprehensive Physiology","first-page":"1473","article-title":"Hepatic stellate cells and liver fibrosis","author":"Puche","year":"2013"},{"issue":"6","key":"10.1016\/j.phrs.2021.105739_bib19","first-page":"509","article-title":"Elizaveta Nilolaevna Levkovich-75th birthday","volume":"19","author":"Pogodina","year":"1975","journal-title":"Acta Virol."},{"issue":"2","key":"10.1016\/j.phrs.2021.105739_bib20","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.bpg.2011.02.005","article-title":"Mechanisms of hepatic fibrogenesis","volume":"25","author":"Lee","year":"2011","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"issue":"1\u20132","key":"10.1016\/j.phrs.2021.105739_bib21","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.cca.2005.06.014","article-title":"Mechanisms of liver fibrosis","volume":"364","author":"Tsukada","year":"2006","journal-title":"Clin. Chim. Acta"},{"issue":"2","key":"10.1016\/j.phrs.2021.105739_bib22","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/hep.21984","article-title":"Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: validating the European Liver Fibrosis Panel and exploring simple markers","volume":"47","author":"Guha","year":"2007","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.phrs.2021.105739_bib23","doi-asserted-by":"crossref","first-page":"550","DOI":"10.4254\/wjh.v5.i10.550","article-title":"Lipotoxicity in the liver","volume":"5","author":"Z\u00e1mb\u00f3","year":"2013","journal-title":"World J. Hepatol."},{"key":"10.1016\/j.phrs.2021.105739_bib24","first-page":"12","article-title":"Fatty liver and lipotoxicity","author":"Trauner","year":"1801","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.phrs.2021.105739_bib25","unstructured":"H. Malhi, Molecular mechanisms of lipotoxicity in nonalcoholic fatty liver disease, Published online, (2010) 16."},{"issue":"4","key":"10.1016\/j.phrs.2021.105739_bib26","doi-asserted-by":"crossref","DOI":"10.1111\/jpi.12404","article-title":"Melatonin protects against lipid-induced mitochondrial dysfunction in hepatocytes and inhibits stellate cell activation during hepatic fibrosis in mice","volume":"62","author":"Das","year":"2017","journal-title":"J. Pineal Res."},{"issue":"3","key":"10.1016\/j.phrs.2021.105739_bib27","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0168-8278(98)80073-1","article-title":"Non-alcoholic steatohepatitis (NASH): a disease of emerging identity and importance","volume":"29","author":"James","year":"1998","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.phrs.2021.105739_bib28","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3390\/cells9010024","article-title":"Metabolic hallmarks of hepatic stellate cells in liver fibrosis","volume":"9","author":"Khomich","year":"2019","journal-title":"Cells"},{"issue":"5","key":"10.1016\/j.phrs.2021.105739_bib29","first-page":"629","article-title":"Hepatic stellate cell activation: a source for bioactive lipids","volume":"1864","author":"Shmarakov","year":"2019","journal-title":"Biochim. Biophys. Acta BBA Mol. Cell Biol. Lipids"},{"issue":"6","key":"10.1016\/j.phrs.2021.105739_bib30","first-page":"344","article-title":"Cellular and molecular functions of hepatic stellate cells in inflammatory responses and liver immunology","volume":"3","author":"Weiskirchen","year":"2014","journal-title":"HepatoBiliary Surg. Nutr."},{"issue":"4","key":"10.1016\/j.phrs.2021.105739_bib31","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S1665-2681(19)32127-1","article-title":"Liver fibrosis and inflammation. A review","volume":"2","author":"Stalnikowitz","year":"2003","journal-title":"Ann. Hepatol."},{"key":"10.1016\/j.phrs.2021.105739_bib32","unstructured":"F. Marra, Chemokines in liver inflammation and fibrosis, 16."},{"issue":"11","key":"10.1016\/j.phrs.2021.105739_bib33","doi-asserted-by":"crossref","first-page":"6812","DOI":"10.4049\/jimmunol.166.11.6812","article-title":"CD40 activates NF-\u03baB and c-Jun N-Terminal Kinase and enhances chemokine secretion on activated human hepatic stellate cells","volume":"166","author":"Schwabe","year":"2001","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.phrs.2021.105739_bib34","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.febslet.2007.11.057","article-title":"Inflammation and insulin resistance","volume":"582","author":"de Luca","year":"2008","journal-title":"FEBS Lett."},{"issue":"2\u20133","key":"10.1016\/j.phrs.2021.105739_bib35","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1159\/000356535","article-title":"Chronic low-grade inflammation in metabolic disorders: relevance for behavioral symptoms","volume":"21","author":"Lasselin","year":"2014","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.phrs.2021.105739_bib36","first-page":"1","article-title":"Mechanisms linking inflammation to insulin resistance","volume":"2015","author":"Chen","year":"2015","journal-title":"Int. J. Endocrinol."},{"issue":"4","key":"10.1016\/j.phrs.2021.105739_bib37","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1159\/000440905","article-title":"Mechanism of ER stress and inflammation for hepatic insulin resistance in obesity","volume":"67","author":"Kim","year":"2015","journal-title":"Ann. Nutr. Metab."},{"issue":"1\u20132","key":"10.1016\/j.phrs.2021.105739_bib38","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0014-5793(03)00972-4","article-title":"Phosphorylation of insulin receptor substrate-1 serine 307 correlates with JNK activity in atrophic skeletal muscle","volume":"553","author":"Hilder","year":"2003","journal-title":"FEBS Lett."},{"key":"10.1016\/j.phrs.2021.105739_bib39","series-title":"Guanylate Cyclase and Cyclic GMP. Vol 1020. Methods in Molecular Biology","first-page":"17","article-title":"cGMP-dependent protein Kinases (cGK)","author":"Hofmann","year":"2013"},{"key":"10.1016\/j.phrs.2021.105739_bib40","doi-asserted-by":"crossref","first-page":"548","DOI":"10.3389\/fphar.2020.00548","article-title":"Targeting hepatic stellate cells for the treatment of liver fibrosis by natural products: is it the dawning of a new era?","volume":"11","author":"Chan","year":"2020","journal-title":"Front. Pharm."},{"issue":"5","key":"10.1016\/j.phrs.2021.105739_bib41","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1159\/000472410","article-title":"LincRNA-p21 inhibits the Wnt\/\u03b2-Catenin pathway in activated hepatic stellate cells via sponging microRNA-17-5p","volume":"41","author":"Yu","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"issue":"1\u20133","key":"10.1016\/j.phrs.2021.105739_bib42","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.2741\/1616","article-title":"Role of cyclic GMP in gene regulation","volume":"10","author":"Pilz","year":"2005","journal-title":"Front. Biosci."},{"issue":"3","key":"10.1016\/j.phrs.2021.105739_bib43","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.metabol.2008.09.025","article-title":"Evaluation of endogenous nitric oxide synthesis in congenital urea cycle enzyme defects","volume":"58","author":"Nagasaka","year":"2009","journal-title":"Metabolism"},{"issue":"Suppl 1","key":"10.1016\/j.phrs.2021.105739_bib44","article-title":"cGMP-dependent protein Kinase I (cGKI) modulates human hepatic stellate cell activation","volume":"67","author":"Franko","year":"2018","journal-title":"Diabetes"},{"key":"10.1016\/j.phrs.2021.105739_bib45","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.vph.2018.05.011","article-title":"Protein tyrosine phosphatase 1B regulates endothelial endoplasmic reticulum stress; role in endothelial dysfunction","volume":"109","author":"Thiebaut","year":"2018","journal-title":"Vasc. Pharm."},{"key":"10.1016\/j.phrs.2021.105739_bib46","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.tox.2015.08.006","article-title":"Protein tyrosine phosphatase 1B (PTP1B): a key regulator and therapeutic target in liver diseases","volume":"337","author":"Chen","year":"2015","journal-title":"Toxicology"},{"key":"10.1016\/j.phrs.2021.105739_bib47","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.taap.2015.12.021","article-title":"PTP1B confers liver fibrosis by regulating the activation of hepatic stellate cells","volume":"292","author":"Chen","year":"2016","journal-title":"Toxicol. Appl. Pharm."},{"issue":"1","key":"10.1016\/j.phrs.2021.105739_bib48","doi-asserted-by":"crossref","first-page":"10993","DOI":"10.1038\/ncomms10993","article-title":"MicroRNA-378 limits activation of hepatic stellate cells and liver fibrosis by suppressing Gli3 expression","volume":"7","author":"Hyun","year":"2016","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.phrs.2021.105739_bib49","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.3390\/cancers11111738","article-title":"The role and function of microRNA in the pathogenesis of multiple myeloma","volume":"11","author":"Handa","year":"2019","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.phrs.2021.105739_bib50","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3892\/ijmm.2013.1356","article-title":"Activation of hepatic stellate cells is suppressed by microRNA-150","volume":"32","author":"Zheng","year":"2013","journal-title":"Int. J. Mol. Med."},{"issue":"1","key":"10.1016\/j.phrs.2021.105739_bib51","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s13578-018-0259-6","article-title":"The roles of lncRNA in hepatic fibrosis","volume":"8","author":"Peng","year":"2018","journal-title":"Cell Biosci."}],"updated-by":[{"DOI":"10.1016\/j.phrs.2023.106673","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000}}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661821003236?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661821003236?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T14:01:51Z","timestamp":1697205711000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661821003236"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":51,"alternative-id":["S1043661821003236"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2021.105739","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.phrs.2023.106673","asserted-by":"object"}]},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatic stellate cells role in the course of metabolic disorders development \u2013 A molecular overview","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2021.105739","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105739"}}